TrueWealth LLC’s PDL BioPharma, Inc. PDLI Stock Holding History

TrueWealth LLC’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2K	Hold	800	–	–	﹤0.01%	659
2020 Q1	$2K	Hold	800	–	–	﹤0.01%	671
2019 Q4	$3K	Hold	800	–	–	﹤0.01%	659
2019 Q3	$2K	Hold	800	–	–	﹤0.01%	660
2019 Q2	$3K	Hold	800	–	–	﹤0.01%	643
2019 Q1	$3K	Hold	800	–	–	﹤0.01%	654
2018 Q4	$2K	Hold	800	–	–	﹤0.01%	682
2018 Q3	$2K	Hold	800	–	–	﹤0.01%	752
2018 Q2	$2K	Hold	800	–	–	﹤0.01%	761
2018 Q1	$2K	Hold	800	–	–	﹤0.01%	730
2017 Q4	$2K	Buy	+800	New	+$2.46K	﹤0.01%	833

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

TrueWealth LLC's PDLI Position: Q2 2020 in Review

TrueWealth LLC held its PDL BioPharma, Inc. (PDLI) position steady in Q2 2020 at 800 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

TrueWealth LLC first reported a position in PDLI in Q4 2017 and has held it in 11 quarters since. The position peaked at $3K in Q4 2019. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

TrueWealth LLC held 800 shares of PDL BioPharma, Inc. worth $2K as of Q2 2020.
TrueWealth LLC left its PDL BioPharma, Inc. share count unchanged in Q2 2020.
PDL BioPharma, Inc. made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #659 holding.
TrueWealth LLC first reported a position in PDL BioPharma, Inc. in Q4 2017 and has held it in 11 quarters since.
TrueWealth LLC's PDL BioPharma, Inc. position peaked at $3K in Q4 2019.
136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.